A distinctive feature found in eukaryotic mRNA and sev eral small RNAs is the presence of a cap structure (m7GpppN, where N is any nucleotide) at the 5' terminus.1 The cap structure serves as a multi-purpose modification that is recognized by many cellular proteins involved in premRNA splicing, RNA export, translation initiation and RNA turnover.2 Proteins that interact with the cap structure include the cap binding complex (CBC) that plays a major role in RNA processing by activating pre-mRNA splicing and nucleocytoplasmic transport of small snRNAs, eukaryotic translation initiation factors (elFs) that initiate translation of processed mRNAs, as well as the Dcpl/Dcp2 complex which mediates the hydrolysis of the cap structure (decapping) prior to the 5' -► 3; decay of RNA.3"7
A method has been developed for synthesising fluorescentiy labeled capped mRNA. The method incorporates a single fluorescent molecule as part o f the 5'-mRNA or oligonucleotide cap site. The fluorescent molecule, Ant-m7GTP is specifically incorporated into the cap site to yield Ant-m7GpppG-capped mRNA or oligonucleotide. Efficient capping was observed with 60-100% o f the RNA transcripts capped with the fluorescent molecule. The Ant-m7G derivative, which has been previously shown to interact with the eukaryotic cap binding protein elF4E, is shown in this paper to be a substrate for the Vaccinia capping enzyme and the DCP2 decapping enzyme from Arabidopsis. Further, the Antm 7GTP-capped RNA is readily translated. This Ant-m7GTP-capped RNA provides an important tool for monitoring capping reactions, translation, and biophysical studies.
A distinctive feature found in eukaryotic mRNA and sev eral small RNAs is the presence of a cap structure (m7GpppN, where N is any nucleotide) at the 5' terminus.1 The cap structure serves as a multi-purpose modification that is recognized by many cellular proteins involved in premRNA splicing, RNA export, translation initiation and RNA turnover.2 Proteins that interact with the cap structure include the cap binding complex (CBC) that plays a major role in RNA processing by activating pre-mRNA splicing and nucleocytoplasmic transport of small snRNAs, eukaryotic translation initiation factors (elFs) that initiate translation of processed mRNAs, as well as the Dcpl/Dcp2 complex which mediates the hydrolysis of the cap structure (decapping) prior to the 5' -► 3; decay of RNA.3"7
Analogs of the mRNA cap have been instrumental in the study of cap-associated processes, in particular, cap-dependent transla tion. ' n It has been demonstrated that 7-methylguanosine, ribose and phosphoryl moieties are the minimal structural requirements for cap analogs.12 Numerous cap analogs have been synthesized and have been instrumental in biophysical studies of cap binding, in assessing the determinants of translation inhibition, in the puri fication of a range of eIF4E proteins and in the priming of in vitro transcription reactions to synthesize capped RNA.8,13"17 In vivo, the cap structure is attached to an mRNA transcript, at the stage of 25-30 nucleotides by consecutive enzymatic reac tions catalyzed by triphosphatase, guanylyltransferase, and methyltransferase activities.1'2'18-24 The reactions are shown below:
This pathway seems to be conserved, although very few exam ples have been characterized in detail.25 The consecutive enzy matic activities of capping have been primarily determined using the recombinant Vaccinia capping enzyme.18'20 Capping involves the sequential hydrolysis of a monophosphate group from triphosphorylated RNA, transfer of a GMP moiety to the diphosphorylated RNA transcript and the acceptance of a single methyl group from S-adenosylmethionine to the seventh position of guanine moiety.18'19'25 The recombinant Vaccinia capping enzyme has been used to synthesize radiolabeled capped RNA, primarily in studies on the capping and the decapping processes.6'18
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